West Pharmaceutical Services Inc (WST)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 2,682,300 | 2,881,000 | 2,684,900 | 2,335,400 | 1,854,500 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $2,682,300K
= 0.00
The debt-to-equity ratio of West Pharmaceutical Services Inc has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt financing to support its operations and growth, relying solely on equity to fund its activities. A debt-to-equity ratio of 0.00 signifies a very conservative financial structure, where the company is not relying on external borrowing for its capital needs. This could imply a lower financial risk as the company is not exposed to potential issues related to high debt levels.
Peer comparison
Dec 31, 2024